Page last updated: 2024-10-30

ketotifen and Chloasma

ketotifen has been researched along with Chloasma in 1 studies

Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dias, JAF1
Lima, PB1
Cassiano, DP1
EspĆ³sito, ACC1
Bagatin, E1
Miot, LDB1
Miot, HA1

Trials

1 trial available for ketotifen and Chloasma

ArticleYear
Oral ketotifen associated with famotidine for the treatment of facial melasma: a randomized, double-blind, placebo-controlled trial.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2022, Volume: 36, Issue:2

    Topics: Double-Blind Method; Famotidine; Humans; Ketotifen; Melanosis

2022